Investor Relations

IR Home

Webcast ImageWebcast
Q2 2016 Vanda Pharmaceuticals Inc. Earnings Conference Call (Live)
07/27/16 at 4:30 p.m. ET
Q2 2016 Vanda Pharmaceuticals Inc. Earnings Conference Call
Wednesday, July 27, 2016 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Stock Chart
VNDA (Common)
ExchangeNASDAQ (US Dollar)
Price$11.13
Change (%) Stock is Down 0.03 (0.27%)
Volume119,778
Data as of 07/26/16 11:39 a.m. ET
Minimum 20 minute delay
Refresh quote
Latest Presentation
Download Documentation JMP Securities 2016 Life Sciences Conference Presentation
July 2016?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-5-4-3-2-112
3456789
10111213141516
17181920212223
24252627282930
31515253545556

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Senior Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Recent News
07/12/16
Vanda Pharmaceuticals to Announce Second Quarter 2016 Financial Results on July 27, 2016
06/20/16
Vanda Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
06/15/16
FDA Grants Fanapt® Three Years of Marketing Exclusivity for Labeling Changes Relating to Maintenance Treatment of Schizophrenia
More >>
Upcoming Events
Q2 2016 Vanda Pharmaceuticals Inc. Earnings Conference Call
Wednesday, July 27, 2016 4:30 p.m. ET

More >>

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2007 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy